Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder
Fulton F Velez,1 Sam Colman,2 Laura Kauffman,2 Charles Ruetsch,3 Kathryn Anastassopoulos,2 Yuri A Maricich1 1Pear Therapeutics, Inc., Boston, MA, USA; 2Covance Market Access, Gaithersburg, MD, USA; 3Health Analytics, Columbia, MD, USACorrespondence: Fulton F VelezPear Therapeutics, Inc., 200 State S...
Main Authors: | Velez FF, Colman S, Kauffman L, Ruetsch C, Anastassopoulos K, Maricich YA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-10-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/comparison-of-healthcare-resource-utilization-between-patients-who-eng-peer-reviewed-fulltext-article-CEOR |
Similar Items
-
Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative
by: Dara Kusic, et al.
Published: (2022-09-01) -
Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse
by: Vanessa Troiani, et al.
Published: (2021-10-01) -
Linking the gut microbiome to microglial activation in opioid use disorder
by: Danielle Antoine, et al.
Published: (2022-12-01) -
Editorial: Opioids and opioid-use disorders
by: Giordano de Guglielmo, et al.
Published: (2023-06-01) -
The impact of the opioid crisis on U.S. state prison systems
by: Christy K. Scott, et al.
Published: (2021-07-01)